Skip to main content
. Author manuscript; available in PMC: 2012 Nov 5.
Published in final edited form as: Mult Scler. 2010 Feb 11;16(4):387–397. doi: 10.1177/1352458509359722

Table 2.

Baseline subject demographics:

Formulation A
N=8*
Formulation B
N=8
Formulation C
N=8
Total
N=24
Gender, M/F 3/5 3/5 1/7 7/17
Age (years)
 Median 48.5 52 50.5 51
 Range 36–66 27–77 42–65 27–77
Race
 Caucasian 8 8 8 24
 Non-Caucasian 0 0 0 0
Type of MS
 Relapsing-remitting 4 3 5 12
 Primary progressive 1 0 0 1
 Secondary progressive 3 5 3 11
MS duration median (range in yrs) 11.5 (1–16) 21 (8–33) 11.5 (2–35) 12.5 (1–35)
EDSS median (range) 4.0 (2.0–7.0) 5.0 (2.5–7.5) 4.0 (2.0–8.0) 4.0 (2.0–8.0)
*

N denotes the number of subjects in each treatment group.